Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

Bank Central Asia Tbk PT

Start price
Target price
Perf. (%)
€0.54
02.05.23
-
02.05.24
13.48%
29.04.24

buy
Baidu Inc. A ADR

Start price
Target price
Perf. (%)
€110.20
01.05.23
€145.79
01.05.24
-8.53%
09:17

buy
Baidu Inc. A ADR

Start price
Target price
Perf. (%)
€110.20
01.05.23
€145.79
01.05.24
-8.53%
09:17

BioLase Inc.

Start price
Target price
Perf. (%)
€0.23
30.04.23
-
30.04.24
-71.09%
14.06.23

China Natural Res

Start price
Target price
Perf. (%)
€1.04
30.04.23
-
30.04.24
-
30.09.21

Euro Tech Holdings

Start price
Target price
Perf. (%)
€2.62
30.04.23
-
30.04.24
-
30.09.21

buy
Iridex Corp.

Start price
Target price
Perf. (%)
€6.10
30.04.23
-
30.04.24
-
18.08.21

InVivo Therapeutics Holdings

Start price
Target price
Perf. (%)
€1.22
30.04.23
-
30.04.24
-79.07%
29.04.24

Polar Power Inc

Start price
Target price
Perf. (%)
€1.04
30.04.23
-
30.04.24
-70.62%
25.04.24

buy
Cameco Corp.

Start price
Target price
Perf. (%)
€23.13
12.10.22
€62.00
12.01.27
101.11%
09:13

Could be worthwhile Investment >10% per year
Market Leader or Top 3
Very Future proof/growth oriented business model
buy
Cameco Corp.

Start price
Target price
Perf. (%)
€23.13
12.10.22
€62.00
12.01.27
101.11%
09:13

Could be worthwhile Investment >10% per year
Market Leader or Top 3
Very Future proof/growth oriented business model
buy
Celldex Therapeutics

Start price
Target price
Perf. (%)
€29.80
07.09.22
€50.00
31.12.25
12.75%
08:00

Could be very worthwhile Investment >20% year
buy
BP plc

Start price
Target price
Perf. (%)
€3.64
08.07.21
-
16.06.25
89.20%
09:12

buy
BP plc

Start price
Target price
Perf. (%)
€3.64
08.07.21
-
16.06.25
89.20%
09:12

buy
FuelCell Energy Inc.

Start price
Target price
Perf. (%)
€8.80
14.06.21
€20.00
19.12.24
-90.00%
-

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected